Bispecific antibodies target two antigens at once. Biointron explores their formats, advantages, and therapeutic potential across cancer, immunology, and emerging indications.
VHH antibodies offer stability, small size, and unique binding advantages. Biointron highlights their history, applications, and growing role in research and therapeutics.
Monoclonal, polyclonal, and recombinant—what they are, how they’re made, and where each excels, with practical use cases researchers can apply in the lab and clinic.
Our website uses cookies to improve your experience. Read our Privacy Policy to find out more.


